Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Harvard Business School
Medtronic
AstraZeneca
Dow

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Valerian

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Valerian?

Valerian is an investigational drug.

There have been 8 clinical trials for Valerian. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2009.

The most common disease conditions in clinical trials are Anxiety Disorders, Depressive Disorder, and Depression. The leading clinical trial sponsors are Pascoe Pharmazeutische Praeparate GmbH, Millet Roux, and Marjan Industria e Comercio ltda.

Recent Clinical Trials for Valerian
TitleSponsorPhase
Therapeutic Effect of an Herbal Medicine on AnxietyMillet RouxPhase 3
Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate AnxietyMarjan Industria e Comercio ltdaPhase 3
Efficacy and Safety of St. John´s Wort/Valerian Extract Versus Placebo in Children and Adolescents With ADHDSteiner Arzneimittel, Berlin, GermanyPhase 3

See all Valerian clinical trials

Clinical Trial Summary for Valerian

Top disease conditions for Valerian
Top clinical trial sponsors for Valerian

See all Valerian clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Colorcon
McKinsey
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.